Transcripts

Alnylam Pharmaceuticals (ALNY) earnings call transcripts

Earnings call transcripts for Alnylam Pharmaceuticals, Inc., with a summary, the guidance given, and what analysts pressed on.

  • Q2 2026 earnings call

    Management framed the call around a strong launch and durable TTR opportunity, while acknowledging its original 2026 demand assumptions were too optimistic.

    Jul 30, 2026Positive0.55